However, no significant changes in inflammatory biomarkers like MMP-9 and ICAM-1 underscores the complexity of immune modulation in DKD, indicating that multiple therapeutic mechanisms may be involved. The gene discussed is ICAM1; the disease is diabetic kidney disease.